Euro Diabetes Index 2014

PROMOTED CONTENT: This post is sponsored by a third party.

The 2014 Euro Diabetes Index was presented at the 50th Congress of the European Association for the Study of Diabetes (EASD) in Vienna. It is a tool for awareness and advocacy at national and European level to empower patients and physicians through comparing and reviewing health care provision and policies regarding diabetes in all member states plus Norway and Switzerland.

Key Findings:

Prevention

  • Public health programmes have not reached their goals to modify risk factors for diabetes

Case finding

  • National Diabetes Registry is limited and restricted
  • Diabetes screening is random and unsystematic
  • Gestational diabetes screening of women is non-standardised and inconsistent

Range and reach of services

  • Special footwear is restricted to one pair per year for both adults and children
  • Podiatric care is a private expense in some countries
  • Eye care is available in most countries
  • Medication non-adherence is high

Access to treatment or care

  • Insulin pump therapies are limited
  • Continuous glucose monitoring use is restricted
  • Glucose test strips are insufficient for patients
  • Patient education programmes are of varying quality and lack continuity
  • General physicians have not received training on recommended standards of diabetes care

Procedures

  • Data is lacking in many countries on monitoring plans and annual checks for diabetes and comorbidities

Outcomes

  • Many countries have unreliable or no information available on the outcomes of their diabetes treatment and plan

Learn more at: http://www.healthpowerhouse.com/index.php?option=com_content&view=category&layout=blog&id=46&Itemid=66